INIS
immunoglobulins
100%
patients
75%
anchors
75%
nerves
50%
stimulation
50%
size
50%
values
25%
information
25%
fibers
25%
comparative evaluations
25%
muscles
25%
distribution
25%
scanning electron microscopy
25%
Keyphrases
Randomized Trial
100%
Myasthenia Gravis
100%
Minimal Clinically Important Difference
100%
Intravenous Immunoglobulin (IVIg)
44%
Anchor-based
33%
Quantitative Myasthenia Gravis Score
33%
Placebo
22%
Change Score
22%
Repetitive Nerve Stimulation
22%
Clinically Significant
11%
Clinical Significance
11%
Difference Method
11%
Difference Analysis
11%
Distribution-based
11%
Clinically Significant Change
11%
Placebo Study
11%
Single-fiber Electromyography
11%
Medicine and Dentistry
Minimal Clinically Important Difference
100%
Myasthenia gravis
100%
Immunoglobulin
44%
Placebo
22%
Effect Size
22%
Repetitive Nerve Stimulation
22%
Clinical Significance
11%
Scanning Electron Microscopy
11%
Electromyography
11%
Placebo Studies
11%
Pharmacology, Toxicology and Pharmaceutical Science
Myasthenia gravis
100%
Immunoglobulin
57%
Placebo
42%
Scanning Electron Microscopy
14%
Biochemistry, Genetics and Molecular Biology
Intravenous Immunoglobulin
100%
Repetitive Nerve Stimulation
50%
Scanning Electron Microscopy
25%
Electromyography
25%
Immunology and Microbiology
Myasthenia gravis
100%
Intravenous Immunoglobulin
57%
Scanning Electron Microscopy
14%
Muscle
14%